跳至主要内容
临床试验/KCT0004972
KCT0004972
已完成
未知

Investigation of Combined Treatment of Acupuncture and Neurofeedback for Improving Cognitive Function in Mild Neurocognitive Disorder: a randomized, assessor-blind, pilot study

Daejeon Korean Medicine Hospital of Daejeon University0 个研究点目标入组 44 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
Daejeon Korean Medicine Hospital of Daejeon University
入组人数
44
状态
已完成
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
2022年2月18日
最后更新
4年前
研究类型
Interventional Study
性别
All

研究者

发起方
Daejeon Korean Medicine Hospital of Daejeon University

入排标准

入选标准

  • 1\) Mild Neurocognitive Disorder patients who meet Diagnostic and Statistical Manual of Mental Disorders\-5 (DSM\-5\) criteria
  • 2\) Korean version of Montreal Cognitive Assessment (MoCA\-K) scores less than 22
  • 3\) Education level of more than 6 years
  • 4\) Participants who understood the purpose of this study and voluntarily signed the informed consent form

排除标准

  • 1\) Alzheimer, vascular dementia, Parkinson's disease, huntington's disease, hydrocephalus
  • 2\) Presenting mental disorder including schizophrenia, delusional disorder, major depressive disorder, bipolar disorder, alcohol dependence, substance\-related disorders, and etc. based on DSM\-5
  • 3\) Presence or history of neurological disorders, including epilepsy, regional brain damage, head injury, stroke, and etc.
  • 4\) Receiving treatments or participating other clinical study within the last 4 weeks due to Mild Neurocognitive Disorder
  • 5\) Having test for Mild Neurocognitive Disorder within the last 12 weeks
  • 6\) Pregnant or lactating women
  • 7\) Unstable medical state (assessment by research doctor with vital signs, laboratory test, ECG test)
  • 8\) Hypertension, blood pressure excessing 160mmHg systolic and 95mmHg diastolic
  • 9\) Significant liver disease or excessing serum AST, ALT, ?\-GTP levels than twice over references
  • 10\) Unavailable to measure f\-NIRS

结局指标

主要结局

未指定

相似试验